Literature DB >> 14695192

TIP30 deficiency increases susceptibility to tumorigenesis.

Mitsuhiro Ito1, Chao Jiang, Kristy Krumm, Xia Zhang, Jill Pecha, Jian Zhao, Yajun Guo, Robert G Roeder, Hua Xiao.   

Abstract

TIP30, also called CC3 or Htatip2, is a putative metastasis suppressor that promotes apoptosis and inhibits angiogenesis. Although TIP30 has several characteristic features of a tumor suppressor in in vitro analyses, tumor development as a result of TIP30 inactivation has not been demonstrated in vivo, and abnormal expression of TIP30 in human cancer has not been reported. Using genetically engineered mice and cells deficient in TIP30, we show that TIP30-deficient mice have a high incidence of hepatocellular carcinoma and other tumors, and loss of TIP30 enhances susceptibility of fibroblasts to transformation by the SV40 large T antigen. Furthermore, immunohistochemical analysis indicates that reduced TIP30 expression is associated with 33% of human hepatocellular carcinomas. Some of these carcinomas harbor missense mutations in the Tip30 gene, which cause abnormal expression of TIP30. Together, these results demonstrate that the Tip30 gene is a tumor susceptibility gene playing an important role in the suppression of hepatocarcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14695192

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Genome-wide expression profiling reveals transcriptomic variation and perturbed gene networks in androgen-dependent and androgen-independent prostate cancer cells.

Authors:  Ajay P Singh; Sangeeta Bafna; Kunal Chaudhary; Ganesh Venkatraman; Lynette Smith; James D Eudy; Sonny L Johansson; Ming-Fong Lin; Surinder K Batra
Journal:  Cancer Lett       Date:  2007-10-30       Impact factor: 8.679

Review 2.  Tumor suppressor and hepatocellular carcinoma.

Authors:  Juliette Martin; Jean-Francois Dufour
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

3.  Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis.

Authors:  Jin Nakahara; Kohsuke Kanekura; Mikiro Nawa; Sadakazu Aiso; Norihiro Suzuki
Journal:  J Clin Invest       Date:  2008-12-22       Impact factor: 14.808

4.  Release the ink4a/arf growth suppression by "u" and "me"?

Authors:  Shuo Qie; Nianli Sang
Journal:  Cell Cycle       Date:  2011-01-15       Impact factor: 4.534

5.  Overexpression of CC3/TIP30 is associated with HER-2/neu status in breast cancer.

Authors:  Dao-Hai Zhang; Lee Lee Wong; Lee Kian Tai; Evelyn S C Koay; Robert E Hewitt
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-20       Impact factor: 4.553

6.  Clinicopathologic significance and survival of TIP30 expression in laryngeal squamous cell carcinoma.

Authors:  Jianqiu Chen; Chunsheng Zhu; Minhui Zhu; Ming Geng; Yongsheng Tian; Guojun Li; Hongliang Zheng
Journal:  Int J Clin Exp Med       Date:  2015-04-15

7.  A novel TIP30 protein complex regulates EGF receptor signaling and endocytic degradation.

Authors:  Chengliang Zhang; Aimin Li; Xinchun Zhang; Hua Xiao
Journal:  J Biol Chem       Date:  2011-01-20       Impact factor: 5.157

8.  CC3/TIP30 affects DNA damage repair.

Authors:  Sylvia Fong; Frank King; Emma Shtivelman
Journal:  BMC Cell Biol       Date:  2010-04-07       Impact factor: 4.241

9.  Inhibition of nuclear import by the proapoptotic protein CC3.

Authors:  Frank W King; Emma Shtivelman
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  Decreased TIP30 expression promotes tumor metastasis in lung cancer.

Authors:  Xin Tong; Kai Li; Zhigang Luo; Bin Lu; Xing Liu; Tao Wang; Mingshu Pang; Beibei Liang; Min Tan; Mengchao Wu; Jian Zhao; Yajun Guo
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.